Comments

Regeneron Pharmaceuticals Analyst Ratings

REGNNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$746.36

-6.26-0.83%

At close: Dec 16, 4:00 PM EST

$746.36

N/A

After Hours: 4:08 PM EST

Overview News Earnings Options Dividends

Analyst Ratings

Insider Trades Short Interest Government Trades Stock Report

Consensus Rating¹

Buy

Highest Price Target¹

$1175.00

Lowest Price Target¹

$587.00

Consensus Price Target¹

$841.00

Regeneron Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:REGN | Benzinga

Regeneron Pharmaceuticals Inc has a consensus price target of $841 based on the ratings of 27 analysts. The high is $1175 issued by Evercore ISI Group on October 24, 2024. The low is $587 issued by Baird on April 30, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, Wells Fargo, and Canaccord Genuity on December 12, 2025, December 10, 2025, and December 4, 2025, respectively. With an average price target of $856.67 between Morgan Stanley, Wells Fargo, and Canaccord Genuity, there's an implied 14.78% upside for Regeneron Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

Jul

Aug

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Analyst Firms Making Recommendations¹

Morgan Stanley

Wells Fargo

Canaccord Genuity

BMO Capital

Truist Securities

¹calculated from analyst ratings

Analyst Ratings for Regeneron Pharmaceuticals

					Get Alert
Dec 12, 2025	2.9%	Matthew HarrisonMorgan Stanley 61%	767 768	Previous Equal-Weight Current Equal-Weight	Get Alert
Dec 10, 2025	-0.18%	Mohit BansalWells Fargo 68%	700 745	Previous Equal-Weight Current Equal-Weight	Get Alert
Dec 4, 2025	41.62%	John NewmanCanaccord Genuity 49%	850 1.06K	Previous Buy Current Buy	Get Alert
Dec 4, 2025	13.89%	Evan David SeigermanBMO Capital 56%	725 850	Previous Outperform Current Outperform	Get Alert
Dec 3, 2025	2.77%	Matthew HarrisonMorgan Stanley 61%	767 767	Previous Overweight Current Equal-Weight	Get Alert
Nov 24, 2025	6.92%	Gregory RenzaTruist Securities 69%	798 812	Previous Current Buy	Get Alert
Nov 24, 2025	3.17%	Louise ChenScotiabank 60%	650 770	Previous Sector Perform Current Sector Perform	Get Alert
Nov 24, 2025	19.25%	Yifeng LiuHSBC 31%	890	Previous Initiates Current Buy	Get Alert
Nov 20, 2025	-6.21%	Mohit BansalWells Fargo 68%	615 700	Previous Equal-Weight Current Equal-Weight	Get Alert
Nov 7, 2025	-11.57%	Trung HuynhUBS 77%	595 660	Previous Neutral Current Neutral	Get Alert
Oct 29, 2025	-6.21%	Geoff MeachamCitigroup 73%	660 700	Previous Buy Current Buy	Get Alert
Oct 29, 2025	-5.14%	Brian AbrahamsRBC Capital 57%	704 708	Previous Sector Perform Current Sector Perform	Get Alert
Oct 29, 2025	-17.6%	Mohit BansalWells Fargo 68%	580 615	Previous Equal-Weight Current Equal-Weight	Get Alert
Oct 29, 2025	-0.85%	Carter GouldCantor Fitzgerald 63%	678 740	Previous Overweight Current Overweight	Get Alert
Oct 29, 2025	15.9%	Yatin SunejaGuggenheim 75%	815 865	Previous Buy Current Buy	Get Alert
Oct 29, 2025	-15.99%	Tim AndersonB of A Securities 63%	543 627	Previous Underperform Current Underperform	Get Alert
Oct 23, 2025	13.89%	John NewmanCanaccord Genuity 49%	850 850	Previous Buy Current Buy	Get Alert
Oct 14, 2025	13.89%	John NewmanCanaccord Genuity 49%	850 850	Previous Buy Current Buy	Get Alert
Oct 13, 2025	-11.57%	Geoff MeachamCitigroup 73%	650 660	Previous Buy Current Buy	Get Alert
Oct 10, 2025	1.29%	Matthew HarrisonMorgan Stanley 61%	756 761	Previous Overweight Current Overweight	Get Alert
Aug 27, 2025	4.64%	William PickeringBernstein 47%	753 781	Previous Outperform Current Outperform	Get Alert
Aug 27, 2025	11.34%	Akash TewariJefferies 52%	813 831	Previous Buy Current Buy	Get Alert
Aug 11, 2025	8.79%	Srikripa DevarakondaTruist Securities 71%	812 940	Previous Buy Current Buy	Get Alert
Aug 4, 2025	-14.25%	Evan David SeigermanBMO Capital 56%	600 640	Previous Outperform Current Outperform	Get Alert
Aug 4, 2025	1.96%	Matthew HarrisonMorgan Stanley 61%	754 761	Previous Overweight Current Overweight	Get Alert
Aug 4, 2025	-6.88%	Brian AbrahamsRBC Capital 57%	688 695	Previous Sector Perform Current Sector Perform	Get Alert
Aug 4, 2025	9.2%	Yatin SunejaGuggenheim 75%	810 815	Previous Buy Current Buy	Get Alert
Jul 23, 2025	13.89%	John NewmanCanaccord Genuity 49%	850 850	Previous Buy Current Buy	Get Alert
Jul 11, 2025	-21.75%	Trung HuynhUBS 77%	560 584	Previous Neutral Current Neutral	Get Alert
Jul 10, 2025	1.02%	Matthew HarrisonMorgan Stanley 61%	754 755	Previous Overweight Current Overweight	Get Alert
Jun 9, 2025	7.19%	Chris SchottJP Morgan 65%	800 950	Previous Overweight Current Overweight	Get Alert
Jun 5, 2025	-24.97%	Trung HuynhUBS 77%	560 633	Previous Neutral Current Neutral	Get Alert
Jun 2, 2025	-12.91%	Geoff MeachamCitigroup 73%	650 700	Previous Buy Current Buy	Get Alert
Jun 2, 2025	-19.61%	Evan David SeigermanBMO Capital 56%	600 800	Previous Outperform Current Outperform	Get Alert
Jun 2, 2025	1.16%	Matthew HarrisonMorgan Stanley 61%	755 958	Previous Overweight Current Overweight	Get Alert
May 30, 2025	-22.29%	Mohit BansalWells Fargo 68%	580 700	Previous Overweight Current Equal-Weight	Get Alert
May 27, 2025	26.35%	Brian AbrahamsRBC Capital 57%	943 943	Previous Outperform Current Outperform	Get Alert
May 14, 2025	-6.21%	Geoff MeachamCitigroup 73%	600 700	Previous Neutral Current Buy	Get Alert
May 5, 2025	28.36%	Matthew HarrisonMorgan Stanley 61%	958 1.08K	Previous Overweight Current Overweight	Get Alert
May 1, 2025	8.53%	Yatin SunejaGuggenheim 75%	810 940	Previous Buy Current Buy	Get Alert
Apr 30, 2025	27.28%	Chris SchottJP Morgan 65%	950 1K	Previous Overweight Current Overweight	Get Alert
Apr 30, 2025	25.94%	Srikripa DevarakondaTruist Securities 71%	940 975	Previous Buy Current Buy	Get Alert
Apr 30, 2025	7.72%	Salveen RichterGoldman Sachs 57%	804 917	Previous Buy Current Buy	Get Alert
Apr 30, 2025	26.35%	Brian AbrahamsRBC Capital 57%	943 1.05K	Previous Outperform Current Outperform	Get Alert
Apr 30, 2025	-6.21%	Mohit BansalWells Fargo 68%	700 750	Previous Overweight Current Overweight	Get Alert
Apr 30, 2025	7.19%	Evan David SeigermanBMO Capital 56%	800 865	Previous Outperform Current Outperform	Get Alert
Apr 30, 2025	-15.19%	Trung HuynhUBS 77%	633 768	Previous Neutral Current Neutral	Get Alert
Apr 30, 2025	-21.35%	Brian SkorneyBaird 60%	587 652	Previous Neutral Current Neutral	Get Alert
Apr 29, 2025	20.59%	Hartaj SinghOppenheimer 48%	900 925	Previous Outperform Current Outperform	Get Alert
Apr 25, 2025	-12.64%	Brian SkorneyBaird 60%	652 759	Previous Neutral Current Neutral	Get Alert
Apr 23, 2025	30.63%	Srikripa DevarakondaTruist Securities 71%	975 1K	Previous Buy Current Buy	Get Alert
Apr 22, 2025	13.89%	John NewmanCanaccord Genuity 49%	850 1.15K	Previous Buy Current Buy	Get Alert
Apr 22, 2025	-6.88%	Carter GouldCantor Fitzgerald 63%	695	Previous Current Overweight	Get Alert
Apr 17, 2025	-26.71%	Tim AndersonB of A Securities 63%	547 575	Previous Underperform Current Underperform	Get Alert
Apr 14, 2025	22.86%	Salveen RichterGoldman Sachs 57%	917 1.02K	Previous Buy Current Buy	Get Alert
Apr 9, 2025	44.84%	Matthew HarrisonMorgan Stanley 61%	1.08K 1.15K	Previous Overweight Current Overweight	Get Alert
Apr 3, 2025	23.93%	Hartaj SinghOppenheimer 48%	925 950	Previous Outperform Current Outperform	Get Alert
Mar 31, 2025	33.98%	Chris SchottJP Morgan 65%	1K 1.1K	Previous Overweight Current Overweight	Get Alert
Feb 5, 2025	1.69%	Brian SkorneyBaird 60%	759 940	Previous Neutral Current Neutral	Get Alert
Feb 5, 2025	11.74%	David RisingerLeerink Partners 71%	762 834	Previous Market Perform Current Outperform	Get Alert
Jan 28, 2025	2.1%	Andrew BerensLeerink Partners 51%	762 880	Previous Market Perform Current Market Perform	Get Alert
Jan 28, 2025	0.49%	Geoff MeachamCitigroup 73%	750 795	Previous Neutral Current Neutral	Get Alert
Jan 27, 2025	35.73%	Christopher RaymondPiper Sandler 58%	1.01K 1.2K	Previous Overweight Current Overweight	Get Alert
Jan 16, 2025	-1.12%	Trung HuynhUBS 77%	738 1.13K	Previous Buy Current Neutral	Get Alert
Jan 14, 2025	6.52%	Geoff MeachamCitigroup 73%	795 895	Previous Neutral Current Neutral	Get Alert
Jan 10, 2025	27.28%	Hartaj SinghOppenheimer 48%	950 1K	Previous Outperform Current Outperform	Get Alert
Jan 10, 2025	20.59%	Mohit BansalWells Fargo 68%	900 1.05K	Previous Overweight Current Overweight	Get Alert
Jan 8, 2025	34.52%	Srikripa DevarakondaTruist Securities 71%	1K 1.13K	Previous Buy Current Buy	Get Alert
Jan 7, 2025	43.36%	William PickeringBernstein 47%	1.07K 1.11K	Previous Outperform Current Outperform	Get Alert
Dec 10, 2024	-24.3%	Tim AndersonB of A Securities 63%	565	Previous Current Underperform	Get Alert
Nov 15, 2024	54.08%	Alexandria HammondWolfe Research 62%	1.15K	Previous Initiates Current Outperform	Get Alert
Nov 14, 2024	19.92%	Geoff MeachamCitigroup 73%	895	Previous Initiates Current Neutral	Get Alert
Nov 6, 2024	33.98%	Hartaj SinghOppenheimer 48%	1K 1.15K	Previous Outperform Current Outperform	Get Alert
Nov 1, 2024	17.91%	David RisingerLeerink Partners 71%	880 1.08K	Previous Market Perform Current Market Perform	Get Alert
Nov 1, 2024	58.64%	Matthew HarrisonMorgan Stanley 61%	1.18K 1.24K	Previous Overweight Current Overweight	Get Alert
Nov 1, 2024	62.79%	Brian AbrahamsRBC Capital 57%	1.22K 1.26K	Previous Outperform Current Outperform	Get Alert
Nov 1, 2024	42.69%	Carter GouldBarclays 63%	1.07K 1.08K	Previous Overweight Current Overweight	Get Alert
Nov 1, 2024	60.11%	Christopher RaymondPiper Sandler 58%	1.2K 1.24K	Previous Overweight Current Overweight	Get Alert
Nov 1, 2024	59.44%	Evan David SeigermanBMO Capital 56%	1.19K 1.3K	Previous Outperform Current Outperform	Get Alert
Nov 1, 2024	50.87%	Srikripa DevarakondaTruist Securities 71%	1.13K 1.14K	Previous Buy Current Buy	Get Alert
Oct 25, 2024	68.82%	Brian AbrahamsRBC Capital 57%	1.26K 1.26K	Previous Outperform Current Outperform	Get Alert
Oct 24, 2024	57.43%	Cory KasimovEvercore ISI Group 68%	1.18K 1.25K	Previous Outperform Current Outperform	Get Alert
Oct 24, 2024	54.08%	Chris SchottJP Morgan 65%	1.15K 1.2K	Previous Overweight Current Overweight	Get Alert
Oct 23, 2024	35.99%	Olivia BrayerCantor Fitzgerald 59%	1.01K 1.01K	Previous Neutral Current Neutral	Get Alert
Oct 23, 2024	44.7%	Carter GouldBarclays 63%	1.08K 1.22K	Previous Overweight Current Overweight	Get Alert
Oct 22, 2024	40.68%	Mohit BansalWells Fargo 68%	1.05K 1.2K	Previous Overweight Current Overweight	Get Alert
Oct 22, 2024	68.82%	Brian AbrahamsRBC Capital 57%	1.26K 1.26K	Previous Outperform Current Outperform	Get Alert
Oct 16, 2024	52.34%	Srikripa DevarakondaTruist Securities 71%	1.14K 1.2K	Previous Buy Current Buy	Get Alert
Oct 4, 2024	68.82%	Brian AbrahamsRBC Capital 57%	1.25K 1.26K	Previous Outperform Current Outperform	Get Alert
Sep 24, 2024	67.75%	Brian AbrahamsRBC Capital 57%	1.25K 1.28K	Previous Outperform Current Outperform	Get Alert
Sep 24, 2024	74.18%	Evan David SeigermanBMO Capital 56%	1.3K 1.3K	Previous Outperform Current Outperform	Get Alert
Sep 24, 2024	60.78%	Srikripa DevarakondaTruist Securities 71%	1.2K 1.2K	Previous Buy Current Buy	Get Alert
Sep 24, 2024	44.3%	David RisingerLeerink Partners 71%	1.08K 1.18K	Previous Outperform Current Market Perform	Get Alert
Sep 23, 2024	60.78%	Mohit BansalWells Fargo 68%	1.2K 1.2K	Previous Overweight Current Overweight	Get Alert
Sep 17, 2024	71.77%	Brian AbrahamsRBC Capital 57%	1.28K 1.28K	Previous Outperform Current Outperform	Get Alert
Sep 16, 2024	35.99%	Olivia BrayerCantor Fitzgerald 59%	1.01K 1.01K	Previous Neutral Current Neutral	Get Alert
Sep 9, 2024	35.99%	Olivia BrayerCantor Fitzgerald 59%	1.01K 1.01K	Previous Neutral Current Neutral	Get Alert
Sep 9, 2024	71.77%	Brian AbrahamsRBC Capital 57%	1.25K 1.28K	Previous Outperform Current Outperform	Get Alert
Sep 5, 2024	67.48%	Brian AbrahamsRBC Capital 57%	1.25K 1.25K	Previous Outperform Current Outperform	Get Alert
Aug 23, 2024	66.41%	Christopher RaymondPiper Sandler 58%	1.17K 1.24K	Previous Overweight Current Overweight	Get Alert

FAQ

What is the target price for Regeneron Pharmaceuticals (REGN) stock?

The latest price target for Regeneron Pharmaceuticals (NASDAQ:REGN) was reported by Morgan Stanley on December 12, 2025. The analyst firm set a price target for $768.00 expecting REGN to rise to within 12 months (a possible 2.90% upside). 69 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Regeneron Pharmaceuticals (REGN)?

The latest analyst rating for Regeneron Pharmaceuticals (NASDAQ:REGN) was provided by Morgan Stanley, and Regeneron Pharmaceuticals maintained their equal-weight rating.

When was the last upgrade for Regeneron Pharmaceuticals (REGN)?

The last upgrade for Regeneron Pharmaceuticals Inc happened on May 14, 2025 when Citigroup raised their price target to $700. Citigroup previously had a neutral for Regeneron Pharmaceuticals Inc.

When was the last downgrade for Regeneron Pharmaceuticals (REGN)?

The last downgrade for Regeneron Pharmaceuticals Inc happened on December 3, 2025 when Morgan Stanley changed their price target from $767 to $767 for Regeneron Pharmaceuticals Inc.

When is the next analyst rating going to be posted or updated for Regeneron Pharmaceuticals (REGN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Regeneron Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Regeneron Pharmaceuticals was filed on December 12, 2025 so you should expect the next rating to be made available sometime around December 12, 2026.

Is the Analyst Rating Regeneron Pharmaceuticals (REGN) correct?

While ratings are subjective and will change, the latest Regeneron Pharmaceuticals (REGN) rating was a maintained with a price target of $767.00 to $768.00. The current price Regeneron Pharmaceuticals (REGN) is trading at is $746.36, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.